These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9973984)

  • 41. Treatment of metastatic bone lesions in the upper extremity: indications for surgery.
    Muramatsu K; Ihara K; Iwanagaa R; Taguchi T
    Orthopedics; 2010 Nov; 33(11):807. PubMed ID: 21053874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Surgical management of skeletal metastases of the extremities].
    Sabo D; Bernd L
    Orthopade; 1998 May; 27(5):274-81. PubMed ID: 9646318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Osteosynthesis in the metastatic skeletal involvement of breast cancer. Subjective and objective advantages].
    Bertermann O; Senn HJ; Jungi WF; Weber BG
    Dtsch Med Wochenschr; 1983 Mar; 108(13):500-3. PubMed ID: 6832024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Endoprostheses for primary or secondary malignant tumors of bone at the proximal end of femur (author's transl)].
    Knahr K; Salzer M
    Z Orthop Ihre Grenzgeb; 1974 Oct; 112(5):1044-52. PubMed ID: 4280826
    [No Abstract]   [Full Text] [Related]  

  • 45. [Radiotherapy of pathological fractures and skeletal lesions in danger of fractures].
    Rieden K; Kober B; Mende U; zum Winkel K
    Strahlenther Onkol; 1986 Dec; 162(12):742-9. PubMed ID: 2433781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Twenty-year record of osteosynthesis of bone metastases. Analyses of 300 cases].
    Katzner M; Babin SR; Schvingt E
    Int Orthop; 1985; 9(2):89-96. PubMed ID: 4055178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Function-preserving interventions in metastatic fractures].
    Lindecken KD
    Zentralbl Chir; 1984; 109(14):905-9. PubMed ID: 6475371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylactic stabilization for bone metastases, myeloma, or lymphoma: do we need to protect the entire bone?
    Alvi HM; Damron TA
    Clin Orthop Relat Res; 2013 Mar; 471(3):706-14. PubMed ID: 23104043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metastatic breast cancer in the femur. A search for the lesion at risk of fracture.
    Keene JS; Sellinger DS; McBeath AA; Engber WD
    Clin Orthop Relat Res; 1986 Feb; (203):282-8. PubMed ID: 3955991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of pathological fractures of the hip by endoprosthetic replacement.
    Lane JM; Sculco TP; Zolan S
    J Bone Joint Surg Am; 1980 Sep; 62(6):954-9. PubMed ID: 7430183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment for long bone metastases based on a systematic literature review.
    Errani C; Mavrogenis AF; Cevolani L; Spinelli S; Piccioli A; Maccauro G; Baldini N; Donati D
    Eur J Orthop Surg Traumatol; 2017 Feb; 27(2):205-211. PubMed ID: 27650452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endoprosthetic treatment is more durable for pathologic proximal femur fractures.
    Steensma M; Boland PJ; Morris CD; Athanasian E; Healey JH
    Clin Orthop Relat Res; 2012 Mar; 470(3):920-6. PubMed ID: 21879407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathologic fractures due to metastatic disease. A retrospective study of 160 surgically treated fractures.
    Fourneau I; Broos P
    Acta Chir Belg; 1998 Dec; 98(6):255-60. PubMed ID: 9922813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Internal fixation of pathologic fractures. A retrospective study.
    Vander Borght P; Verdonk R; Verstraeten F; Claessens H
    Acta Orthop Belg; 1993; 59 Suppl 1():38-41. PubMed ID: 8116436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endoprosthetic reconstructions for bone metastases.
    Eckardt JJ; Kabo JM; Kelly CM; Ward WG; Cannon CP
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S254-62. PubMed ID: 14600617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy of operative treatment for pathological fractures in bone metastases in relation to length and comfort of survival].
    Dutka J; Sosin P; Urban M
    Chir Narzadow Ruchu Ortop Pol; 2000; 65(6):643-9. PubMed ID: 11388015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Surgical treatment of 24 bone metastases of urogenital origin].
    Katzner M; Steinmetz A; Schvingt E; Viville C
    J Urol Nephrol (Paris); 1979; 85(7-8):463-71. PubMed ID: 529369
    [No Abstract]   [Full Text] [Related]  

  • 58. [Alloplastic bone replacement in resection defects of the long bones].
    Lembcke O; Brutscher R; Rüter A
    Z Orthop Ihre Grenzgeb; 1996; 134(5):441-4. PubMed ID: 8967145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The surgical treatment of metastatic malignant deposits in long bones.
    Critchley JE
    Aust N Z J Surg; 1971 Feb; 40(3):278-84. PubMed ID: 5279441
    [No Abstract]   [Full Text] [Related]  

  • 60. Should the Use of Biologic Agents in Patients With Renal and Lung Cancer Affect Our Surgical Management of Femoral Metastases?
    Gutowski CJ; Zmistowski B; Fabbri N; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2019 Apr; 477(4):707-714. PubMed ID: 30811363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.